Research output: Contribution to journal › Article › peer-review
Solvent Effects in Hyperpolarization of 15N Nuclei in [15N3]Metronidazole and [15N3]Nimorazole Antibiotics via SABRE-SHEATH**. / Yi, Anna P.; Salnikov, Oleg G.; Burueva, Dudari B. et al.
In: Analysis and Sensing, Vol. 4, No. 6, e202400045, 11.2024.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Solvent Effects in Hyperpolarization of 15N Nuclei in [15N3]Metronidazole and [15N3]Nimorazole Antibiotics via SABRE-SHEATH**
AU - Yi, Anna P.
AU - Salnikov, Oleg G.
AU - Burueva, Dudari B.
AU - Chukanov, Nikita V.
AU - Chekmenev, Eduard Y.
AU - Koptyug, Igor V.
N1 - A.P.Y., O.G.S., D.B.B. and N.V.C. thank the Russian ScienceFoundation (grant 21-73-10105). E.Y.C. thanks NSF CHE-1904780and NIBIB R21 EB033872.
PY - 2024/11
Y1 - 2024/11
N2 - Metronidazole and nimorazole are antibiotics of a nitroimidazole group which also may be potentially utilized as hypoxia radiosensitizers for the treatment of cancerous tumors. Hyperpolarization of 15N nuclei in these compounds using SABRE-SHEATH (Signal Amplification By Reversible Exchange in SHield Enables Alignment Transfer to Heteronuclei) approach provides dramatic enhancement of detection sensitivity of these analytes using magnetic resonance spectroscopy and imaging. Methanol-d4 is conventionally employed as a solvent in SABRE hyperpolarization process. Herein, we investigate SABRE-SHEATH hyperpolarization of isotopically labeled [15N3]metronidazole and [15N3]nimorazole in nondeuterated methanol and ethanol solvents. Optimization of such hyperpolarization parameters as polarization transfer magnetic field, temperature, parahydrogen flow rate and pressure allowed us to obtain an average 15N polarization of up to 7.2–7.4 % for both substrates. The highest 15N polarizations were observed in methanol-d4 for [15N3]metronidazole and in ethanol for [15N3]nimorazole. At a clinically relevant magnetic field of 1.4 T the 15N nuclei of these substrates possess long characteristic hyperpolarization lifetimes (T1) of ca. 1 to ca. 7 min. This study represents a major step toward SABRE in more biocompatible solvents, such as ethanol, and also paves the way for future utilization of these hyperpolarized nitroimidazoles as molecular contrast agents for MRI visualization of tumors.
AB - Metronidazole and nimorazole are antibiotics of a nitroimidazole group which also may be potentially utilized as hypoxia radiosensitizers for the treatment of cancerous tumors. Hyperpolarization of 15N nuclei in these compounds using SABRE-SHEATH (Signal Amplification By Reversible Exchange in SHield Enables Alignment Transfer to Heteronuclei) approach provides dramatic enhancement of detection sensitivity of these analytes using magnetic resonance spectroscopy and imaging. Methanol-d4 is conventionally employed as a solvent in SABRE hyperpolarization process. Herein, we investigate SABRE-SHEATH hyperpolarization of isotopically labeled [15N3]metronidazole and [15N3]nimorazole in nondeuterated methanol and ethanol solvents. Optimization of such hyperpolarization parameters as polarization transfer magnetic field, temperature, parahydrogen flow rate and pressure allowed us to obtain an average 15N polarization of up to 7.2–7.4 % for both substrates. The highest 15N polarizations were observed in methanol-d4 for [15N3]metronidazole and in ethanol for [15N3]nimorazole. At a clinically relevant magnetic field of 1.4 T the 15N nuclei of these substrates possess long characteristic hyperpolarization lifetimes (T1) of ca. 1 to ca. 7 min. This study represents a major step toward SABRE in more biocompatible solvents, such as ethanol, and also paves the way for future utilization of these hyperpolarized nitroimidazoles as molecular contrast agents for MRI visualization of tumors.
KW - NMR spectroscopy
KW - SABRE
KW - hyperpolarization
KW - nitroimidazoles
KW - parahydrogen
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85202678011&origin=inward&txGid=60e7595da1b4030fe87678a0fafb8ef4
UR - https://www.mendeley.com/catalogue/9f43ab72-0c14-3bb9-9a8a-f43ed6473c7b/
U2 - 10.1002/anse.202400045
DO - 10.1002/anse.202400045
M3 - Article
VL - 4
JO - Analysis and Sensing
JF - Analysis and Sensing
SN - 2629-2742
IS - 6
M1 - e202400045
ER -
ID: 61106575